TipRanks
PharmaCyte Biotech (DE:EFYA)
STUTTGART:EFYA
Germany Market

PharmaCyte Biotech (EFYA) Cash flow

2 Followers

PharmaCyte Biotech Cash Flow

DE:EFYA's free cash flow for Q1 2027 was $-780.89K. For the 2027 fiscal year, DE:EFYA's free cash flow was decreased by $-2.17M and operating cash flow was $-780.89K. See a summary of the company’s cash flow.
Cash Flow
Apr 26Apr 25Apr 24Apr 23Apr 22
Operating Cash Flow
$ -5.15M$ -2.98M$ -2.15M$ -3.79M$ -4.12M
Investing Cash Flow
$ 2.00M$ -7.00M$ -5.00M$ 0.00$ 0.00
Financing Cash Flow
$ 6.58M$ -25.03M$ -10.71M$ -13.56M$ 87.31M
End Cash Position
$ 18.60M$ 15.17M$ 50.18M$ 68.04M$ 85.40M
Free Cash Flow
$ -5.15M$ -2.98M$ -2.15M$ -3.79M$ -4.12M
Currency in USD

PharmaCyte Biotech Cash Flow